Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Adult alcoholism and attention-deficit hyperactivity disorder are connected


  • Attention-deficit hyperactivity disorder (ADHD) symptoms include inattention, motor hyperactivity and impulsiveness.
  • Researchers have found a distinct phenotype or "profile" of adults with co-existing ADHD and alcoholism.
  • ADHD is five to 10 times more frequent among adult alcoholics than among the normal population.

Investigation of the serotonin transporter gene (5-HTT) and the 5-HT2c receptor Cys23Ser polymorphism does not support a genetic commonality of ADHD and alcoholism.

Attention-deficit hyperactivity disorder (ADHD) symptoms include inattention, motor hyperactivity and impulsiveness. Roughly half of the adults who report ADHD symptoms also report a co-existing substance-abuse disorder. New findings published in the October issue of Alcoholism: Clinical & Experimental Research have identified a distinct phenotype or "profile" of individuals with co-existing ADHD and alcoholism. Although prior studies have suggested a genetic commonality of ADHD and alcoholism, the study found no significant contribution of two specific candidate genes, the promoter polymorphism of the serotonin transporter gene (5-HTT) and the 5-HT2c receptor Cys23Ser polymorphism.

"Our results indicate that individuals with persisting ADHD symptoms in adulthood seem to be at high risk of developing an alcohol-use disorder," said Monika Johann, medical doctor and research associate at the University of Regensburg and first author of the study. "Moreover, there is evidence for a highly increased severity of alcohol dependence in subjects with ADHD."

Researchers examined 314 adult alcoholics (262 males, 52 females) as well as 220 unrelated healthy control subjects, all of German descent. Each participant was assessed for psychiatric disorders, such as substance-use disorders (including alcoholism), ADHD, and antisocial personality disorder (APD). Patients with a history of major psychiatric disorders, including depression and schizophrenia, and those with addictions to drugs other than alcohol and nicotine, were excluded from the investigation. Genotyping was performed without knowledge of diagnostic status, with a focus on the 5-HTT promoter and the 5-HT2c Cys23Ser polymorphism.

"Prior neuroendocrine challenge studies with a drug called fenfluramine in subjects with ADHD or alcoholism revealed similar differences in the serotonergic neurotransmission when compared to normal subjects," explained Johann. "The usual response to fenfluramine administration is a measurable increase in the circulating prolactin. This usual increase is blunted in subjects with ADHD or alcoholism. The main structures responsible for the fenfluramine-induced prolactin release are the 5-HTT and the 5-HT2c receptors. Therefore, both seemed plausible as overlapping sources of genetic liability of ADHD and alcoholism."

Neither of them, however, appear to be genetic risk factors in the sample examined. "Our data demonstrate that the 5-HTT promoter and the 5-HT2c Cys23Ser polymorphism do not contribute to the putative common genetic predisposition for ADHD and alcohol dependence," said Johann. "However, several other candidate genes have yet to be investigated."

Nonetheless, the findings do indicate a distinct phenotype, a way to measure an observable trait or behavior. Adult alcoholics with ADHD had a significantly higher daily and record intake of alcohol per month, an earlier age of onset of alcohol dependence, a higher frequency of thoughts about suicide, a greater number of court proceedings, and a greater occurrence of APD.

Thus, despite the lack of support for a common genetic predisposition, "the data show once again that to have ADHD means to be at high risk for developing alcohol dependence," said Ema Loncarek, a medical doctor and clinician at the psychiatric clinic of the University of Regensburg. Loncarek works on a ward for illegal drug addiction, providing detoxification and therapy.

"Dr. Johann’s findings of a phenotype are very close to what we see in drug addicts with ADHD, and what has been described before by other authors. We see on a regular basis that drug addicts with ADHD are difficult to handle. They start to abuse drugs earlier than other people, change earlier to "hard" drugs, take longer to start treatment, and take longer to successfully finish therapy."

Johann described in more detail the phenotypic variations she and her colleagues found. "Within this group of alcoholics, subjects with ADHD in adulthood are five to 10 times more frequent than in the normal population," she said. "Compared to alcoholics without ADHD, alcoholics with ADHD in adulthood were at least four years younger at onset of alcoholism, drank about 50 grams pure alcohol more per day during the previous month, had a nearly twofold higher rate of first-degree positive family history of alcoholism, had a nearly three times higher frequency of antisocial personality disorder, had a nearly seven times higher frequency of court proceedings, and had a more than two times higher frequency of suicidal thoughts."

Both Johann and Loncarek spoke of a need for the development and evaluation of specialized treatment programs that address "phenotypical specifics" as well as co-existing disorders such as alcoholism and ADHD. While pharmacological remedies, they noted, have been extensively evaluated for the treatment of ADHD in childhood, little attention has been given to substance-abusing individuals with ADHD in adulthood."

"ADHD seems to be highly underestimated in adulthood," said Johann, "yet seems to be an important risk factor for the development of alcohol dependence."

Alcoholism: Clinical & Experimental Research (ACER) is the official journal of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism. Co-authors of the ACER paper included Gabriela Bobbe, Albert Putzhammer, and Norbert Wodarz of the University of Regensburg. The study was partially funded by the University of Regensburg.

Monika Johann | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Thawing permafrost produces more methane than expected

20.03.2018 | Earth Sciences

Scientists invented method of catching bacteria with 'photonic hook'

20.03.2018 | Physics and Astronomy

Next Generation Cryptography

20.03.2018 | Information Technology

Science & Research
Overview of more VideoLinks >>>